In addition, we observed similar results using the BET inhibitor OTX-015 (Birabresib) (Figure S1A,B and Table S1), which is currently in clinical trials for hematologic malignancies and select solid tumors [12]. The gene discussed is DNER; the disease is hematologic disorder.